In response to his good fortune, Roy has committed to leaving an endowment gift to the BC Cancer Foundation, to support ...

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients ...

New robotic technology has arrived at Puyallup’s MultiCare Good Samaritan Hospital – and it creates a world of difference for ...

Deron Wells has been fighting for months to get a double-lung transplant and had to battle his health insurance company in a ...

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA ... patients with previous or current evidence of interstitial lung disease (ILD) were excluded. An Eastern ...

Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ASCO congress. Three of the group’s top cancer drugs were on display – EGFR ...

The FDA has started a priority review of Amgen’s tarlatamab for small cell lung cancer (SCLC), the lead drug in the company’s pipeline of bispecific T-cell engager (BiTE) drugs for solid tumours.

A heart-lung machine allows a person to survive heart surgery that requires the heart to stop, while ECMO assists the heart and lungs when severe illness affects them. Read on to learn more about ...

Phase 2 trial of first-line pembrolizumab with platinum doublet chemotherapy and radiotherapy in patients (pts) with unresectable, locally advanced stage III non–small-cell lung cancer (NSCLC): ...